SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-021528
Filing Date
2020-11-16
Accepted
2020-11-16 11:55:35
Documents
67
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1107521
2 ex31-1.htm EX-31.1 16855
3 ex31-2.htm EX-31.2 16651
4 ex32-1.htm EX-32.1 8538
5 ex32-2.htm EX-32.2 8605
  Complete submission text file 0001493152-20-021528.txt   6222226

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ppcb-20200930.xml EX-101.INS 954404
7 XBRL SCHEMA FILE ppcb-20200930.xsd EX-101.SCH 104591
8 XBRL CALCULATION FILE ppcb-20200930_cal.xml EX-101.CAL 58530
9 XBRL DEFINITION FILE ppcb-20200930_def.xml EX-101.DEF 250521
10 XBRL LABEL FILE ppcb-20200930_lab.xml EX-101.LAB 561492
11 XBRL PRESENTATION FILE ppcb-20200930_pre.xml EX-101.PRE 337724
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

IRS No.: 300662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 201314765
SIC: 2834 Pharmaceutical Preparations